Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.

Kun‐Ming Chan(Chang Gung University), Miin-Fu Chen, Chien‐Fu Hung(Johns Hopkins University), Ming‐Chin Yu, Wei‐Chen Lee(Chang Gung Memorial Hospital), Yi-Yin Jan(Chang Gung Memorial Hospital)

PubMed

August 1, 2005

Cited by 13

Related Papers

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

|Journal of Clinical Oncology|2018|653

Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

|Science Translational Medicine|2017|381

Intraductal papillary neoplasia of the liver associated with hepatolithiasis

|Hepatology|2001|282

Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct—an immunohistochemical study of 110 cases of hepatolithiasis

|Journal of Hepatology|2005|254

Perspectives for therapeutic HPV vaccine development

|Journal of Biomedical Science|2016|231